Randomized comparison between clinical evaluation plus N-terminal pro–B-type natriuretic peptide versus exercise testing for decision making in acute chest pain of uncertain origin - 05/08/11
, Xavier Bosch, MD b, Vicente Bodí, MD a, Julio Núñez, MD a, Ada Doltra, MD b, Magda Heras, MD b, Luis Mainar, MD a, Enrique Santas, MD a, Ernest Bragulat, MD b, Ana García-Alvarez, MD b, Arturo Carratalá, MD c, Angel Llácer, MD aRésumé |
Background |
Exercise testing constitutes the usual tool for decision making in chest pain units. This policy implies logistical constrains. Our aim was to evaluate a new strategy, combining a clinical risk score and N-terminal pro–B-type natriuretic peptide (NT-proBNP), in patients presenting to the emergency department with chest pain, without ischemic electrocardiogram changes or troponin elevation.
Methods |
A total of 320 patients were randomized to either usual management, involving exercise testing, or a new strategy combining a clinical risk score and NT-proBNP without exercise testing. In the usual management, discharge decision was guided by the result of exercise test. In the new strategy, those patients with low clinical risk score and NT-proBNP were directly discharged. The primary outcome was hospitalization at the index episode. Secondary outcomes were cardiac events at 1 year.
Results |
A total of 110 patients (69%) were hospitalized using usual management in comparison with 90 (56%) in the new strategy (P = .03). There were no differences in death or myocardial infarction (n = 11, 6.9% vs n = 6, 3.8%, P = .3) or cardiac events (n = 38, 24% vs n = 28, 18%, P = .2). Revascularizations at the index episode were more frequent under usual management (18% vs 8%, P = .01), although the new strategy was associated with higher rate of planned postdischarge revascularizations (0.6% vs 5%, P = .04).
Conclusions |
A strategy combining clinical history and NT-proBNP is simpler and reduced initial emergency hospitalizations in patients with chest pain, in comparison with the usual strategy involving exercise testing. Larger studies to assess its impact on long-term hard end points are needed. (www.ClinicalTrials.govNCT00493844)
Le texte complet de cet article est disponible en PDF.Plan
| RCT no. NCT00493844. |
Vol 159 - N° 2
P. 176-182 - février 2010 Retour au numéro
Article précédent
- Cardiac DeatH Prevention by aUtomated DefibrillatoRs in ChurcHes: Rationale and design of the CHURCH trial
- Maurizio Ferratini, Andrea Moraschi, Vittorino Ripamonti, Pantaleo Giannuzzi, Francesco Lorito, Gianni De Luca, Niccolò Grieco, Giovanni Sesana, Renata De Maria
- Primary care practices and determinants of optimal anticoagulation management in a collaborative care model
- Kerby Maud Louis, Josée Martineau, Isabel Rodrigues, Martine Fournier, Djamal Berbiche, Normand Blais, Jeffrey Ginsberg, Lucie Blais, Martine Montigny, Sylvie Perreault, Marie-Claude Vanier, Lyne Lalonde
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?